Aesculap Implant Systems established a warranty program for its Plasmapore®XP-coated spinal interbody fusion devices, and launched the TSpace®XP interbody system.
CellRight Technologies launched Matrix OI® Cortical Fibers, the latest in vivo verified osteoinductive matrix in its portfolio of regenerative human-derived osteobiologics.
OrthAlign announced completion of the 60,000th joint arthroplasty case employing the company’s handheld precision alignment and positioning technology.
NuVasive received FDA 510(k) clearance to market the CoRoent® Small Interbody™ System for intervertebral body fusion at multiple contiguous levels in the cervical spine.